Kymera Therapeutics, Inc. - Common Stock - relatórios financeiros (NASDAQ:KYMR) | MetaTrader

Abrir gráfico completo Full chart

Notícias

Kymera apresenta dados do ensaio de KT-621 para dermatite atópica em conferências

Kymera Therapeutics, Inc. (KYMR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Kymera apresenta dados pré-clínicos para candidato a medicamento para DII KT-579

Kymera Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-05-04

KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration

Kymera Therapeutics, Inc. (KYMR) Reports Q1 Loss, Tops Revenue Estimates

Kymera Therapeutics divulga resultados após marco do acordo com a Gilead

Wave Life Sciences (WVE) Reports Q1 Loss, Beats Revenue Estimates

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

FDA concede status de fast track ao KT-621 da Kymera para asma

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

H.C. Wainwright reitera classificação de compra para Kymera Therapeutics